Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Sponsored
Discussion Forum: Awakn Life Sciences Corp.
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
Icon agoracom Awakn Life Sciences Completes World's First Ketamine Treatment Study for a Range of Behavioral Addictions

AGORACOM-NR
May 19, 2022 07:56AM
Icon agoracom Awakn Life Sciences Appoints UK Leader in Addictions Psychiatry, Dr. Arun Dhandayudham, as Chief Medical Officer

AGORACOM-NR
May 17, 2022 07:30AM
Icon agoracom Awakn Life Sciences to Participate in Upcoming May 2022 Conferences

AGORACOM-NR
May 05, 2022 07:30AM
Icon agoracom Awakn Life Sciences Reports Fiscal Fourth Quarter and Fiscal Year January 31, 2022, Results

AGORACOM-NR
Apr 28, 2022 04:28PM
Icon agoracom Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

AGORACOM-NR
Apr 13, 2022 07:30AM
Icon agoracom Awakn Successfully Completes Phase One of Its Drug Discovery Program

AGORACOM-NR
Apr 06, 2022 07:30AM
Icon agoracom Awakn Life Sciences to Participate in Upcoming April 2022 Conferences

AGORACOM-NR
Apr 05, 2022 07:30AM
Icon agoracom Awakn Life Sciences Announces Closing of Private Placement

AGORACOM-NR
Mar 22, 2022 07:30AM
Icon agoracom Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments

AGORACOM-NR
Mar 17, 2022 07:30AM
Icon agoracom Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development

AGORACOM-NR
Mar 15, 2022 07:30AM
Icon agoracom Awakn Life Sciences to Participate at Upcoming March 2022 Conferences

AGORACOM
Mar 09, 2022 07:30AM
Icon agoracom Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules

AGORACOM-NR
Feb 17, 2022 07:45AM
Icon agoracom Awakn Life Sciences' Professor Celia Morgan Named One of the Most Influential Women in the Psychedelics Industry

AGORACOM-NR
Feb 15, 2022 07:30AM
Icon agoracom AGORACOM Small Cap 60: Awakn LifeSciences Has Newly Formed Partnership With UK's NHS

AGORACOM-NR
Feb 14, 2022 03:05PM
Icon agoracom AGORACOM Small Cap 60: Awakn LifeSciences Looks To Commercialize With “Ketamine Clinic In A Box”

AGORACOM-NR
Feb 14, 2022 11:40AM
Icon agoracom AGORACOM Small Cap 60: Awakn Phase II Trial For AUD Exceeds Company Expectations

AGORACOM-NR
Feb 11, 2022 02:25PM
Icon agoracom AGORACOM Small Cap 60: Awakn LifeSciences Aims To Be Leading Company In #Psychedelics Industry Focused On Treating #Addiction

AGORACOM-NR
Feb 10, 2022 12:00PM
Icon agoracom Awakn Life Sciences to Host Fireside Chat with Dr. Ben Sessa, Chief Medical Officer, on March 2nd at 11:00am EST

AGORACOM-NR
Feb 10, 2022 07:30AM
Icon agoracom AGORACOM Small Cap 60: Awakn Life Sciences Aims To Provide Hope For Individuals and Communities That Are Plagued By #Addiction

AGORACOM-NR
Feb 10, 2022 12:20AM
Icon agoracom AGORACOM SmallCap 60: Awakn LifeSciences In discussions for Phase III AUD Trial To Be Run Within NHS Infrastructure

AGORACOM-NR
Feb 09, 2022 01:00PM
New Message